Review Article| Volume 41, ISSUE 2, P197-205, May 2023

Download started.


What Is New in Risk Assessment in Nuclear Cardiology?

Published:February 26, 2023DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Visseren F.L.J.
        • MacH F.
        • Smulders Y.M.
        • et al.
        2021 ESC guidelines on cardiovascular disease prevention in clinical practice.
        Eur Heart J. 2021; 42: 3227-3337
        • Knuuti J.
        • Saraste A.
        • Capodanno D.
        • et al.
        2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. The Task Force for the Diagnosis and Management of Chronic Coronary Syndromes of the European Society of Cardiology (ESC).
        Eur Hear J. 2020; 41: 407-477
        • Verberne H.J.
        • Acampa W.
        • Anagnostopoulos C.
        • et al.
        EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision.
        Eur J Nucl Med Mol Imaging. 2015; 42: 1929-1940
        • Danad I.
        • Raijmakers P.G.
        • Driessen R.S.
        • et al.
        Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve.
        JAMA Cardiol. 2017; 2: 1100-1110
      1. National Institute for Health and Clinical Excellence. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. CG95. London: National Institute for Health and Clinical Excellence; 2010. Last Updated 2016. Accessed February 2023.

        • Gulati M.
        • Levy P.D.
        • Mukherjee D.
        • et al.
        2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
        JACC (J Am Coll Cardiol). 2021; 78: 221
        • Herscovici R.
        • Sedlak T.
        • Wei J.
        • et al.
        Ischemia and no obstructive coronary artery disease (INOCA): what is the risk?.
        J Am Heart Assoc. 2018; 7: e008868
        • Gimelli A.
        • Liga R.
        • Duce V.
        • et al.
        Accuracy of myocardial perfusion imaging in detecting multivessel coronary artery disease: a cardiac CZT study.
        J Nucl Cardiol. 2017; 24: 687-695
        • Zavadovsky K.V.
        • Mochula A.V.
        • Boshchenko A.A.
        • et al.
        Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: correlation and accuracy.
        J Nucl Cardiol. 2021; 28: 249-259
        • Acampa W.
        • Assante R.
        • Mannarino T.
        • et al.
        Low-dose dynamic myocardial perfusion imaging by CZT-SPECT in the identification of obstructive coronary artery disease.
        Eur J Nucl Med Mol Imaging. 2020; 47: 1705-1712
        • Valenta I.
        • Dilsizian V.
        • Quercioli A.
        • et al.
        Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes.
        Curr Cardiol Rep. 2013; 15: 344
        • Herzog B.A.
        • Husmann L.
        • Valenta I.
        • et al.
        Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography. Added value of coronary flow reserve.
        J Am Coll Cardiol. 2009; 54: 150-156
        • Murthy V.L.
        • Naya M.
        • Foster C.R.
        • et al.
        Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
        Circulation. 2011; 124: 2215
        • Ziadi M.C.
        • DeKemp R.A.
        • Williams K.
        • et al.
        Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?.
        J Nucl Cardiol. 2012; 19: 670-768
        • Fiechter M.
        • Ghadri J.R.
        • Gebhard C.
        • et al.
        Diagnostic value of 13N-ammonia myocardial perfusion PET: added value of myocardial flow reserve.
        J Nucl Med. 2012; 53: 1230-1231
        • Wells R.G.
        • Timmins R.
        • Klein R.
        • et al.
        Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model.
        J Nucl Med. 2014; 55: 1685-1691
        • Agostini D.
        • Roule V.
        • Nganoa C.
        • et al.
        First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study.
        Eur J Nucl Med Mol Imaging. 2018; 45 (Available at:): 1079-1090
        • Liga R.
        • Neglia D.
        • Kusch A.
        • et al.
        Prognostic role of dynamic CZT imaging in CAD patients: interaction between absolute flow and CAD burden.
        JACC (J Am Coll Cardiol): Cardiovascular Imaging. 2022; 15: 540-542
        • Neglia D.
        • Liga R.
        • Caselli C.
        • et al.
        Anatomical and functional coronary imaging to predict long-term outcome in patients with suspected coronary artery disease: the EVINCI-outcome study.
        Eur Heart J Cardiovasc Imaging. 2020; 21: 1273-1282
        • Taqueti V.R.
        • Shaw L.J.
        • Cook N.R.
        • et al.
        Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease.
        Circulation. 2017; 135: 566-657
        • Betancur J.
        • Otaki Y.
        • Motwani M.
        • et al.
        Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning.
        JACC Cardiovasc Imaging. 2018; 11: 1000-1009
        • Rios R.
        • Miller R.J.H.
        • Hu L.H.
        • et al.
        Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.
        Cardiovasc Res. 2022; 118: 2152-2164
        • Gehi A.K.
        • Ali S.
        • Na B.
        • et al.
        Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study.
        Arch Intern Med. 2008; 168: 1423-1428
        • Hachamovitch R.
        • Rozanski A.
        • Shaw L.J.
        • et al.
        Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.
        Eur Heart J. 2011; 32: 1012-1024
        • Doenst T.
        • Haverich A.
        • Serruys P.
        • et al.
        PCI and CABG for treating stable coronary artery disease.
        J Am Coll Cardiol. 2019; 73: 964-976
        • Boden W.E.
        • O’Rourke R.A.
        • Teo K.K.
        • et al.
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1511
        • Al-Lamee R.
        • Thompson D.
        • Dehbi H.M.
        • et al.
        Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
        Lancet. 2018; 391: 31-40
        • Cleland J.G.F.
        • Calvert M.
        • Freemantle N.
        • et al.
        The heart failure revascularisation trial (HEART).
        Eur J Heart Fail. 2011; 391: 31-40
        • Stergiopoulos K.
        • Boden W.E.
        • Hartigan P.
        • et al.
        Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia.
        JAMA Intern Med. 2014; 174: 232-240
        • Miller R.J.H.
        • Bonow R.O.
        • Gransar H.
        • et al.
        Percutaneous or surgical revascularization is associated with survival benefit in stable coronary artery disease.
        Eur Heart J Cardiovasc Imaging. 2020; 21: 961-997
        • Hochman J.S.
        • Reynolds H.R.
        • Bangalore S.
        • et al.
        Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial.
        JAMA Cardiol. 2019; 4: 273-286
        • Maron D.J.
        • Hochman J.S.
        • Reynolds H.R.
        • et al.
        Initial invasive or conservative strategy for stable coronary disease.
        N Engl J Med. 2020; 382: 1395-1404
        • Investigators S.-H.
        Coronary CT angiography and 5-year risk of myocardial infarction.
        N Engl J Med. 2018; 379: 924-933
        • Liga R.
        • Neglia D.
        • Cavaleri S.
        • et al.
        Prognostic impact of patients’ management based on anatomic/functional phenotype: a study in patients with chronic coronary syndromes.
        J Nucl Cardiol. 2022;
        • De Bruyne B.
        • Fearon W.F.
        • Pijls N.H.J.
        • et al.
        Fractional flow reserve–guided PCI for stable coronary artery disease.
        N Engl J Med. 2014; 371: 12
        • Liga R.
        • Vontobel J.
        • Rovai D.
        • et al.
        Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population.
        Eur Heart J Cardiovasc Imaging. 2016; 17: 951
        • Werner R.A.
        • Rischpler C.
        • Onthank D.
        • et al.
        Retention kinetics of the 18F-labeled sympathetic nerve PET tracer LMI1195: comparison with 11C-hydroxyephedrine and 123I-MIBG.
        J Nucl Med. 2015; 56: 1429-1433
        • Jacobson A.F.
        • Senior R.
        • Cerqueira M.D.
        • et al.
        Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study.
        J Am Coll Cardiol. 2010; 55: 2212-2222
        • Gimelli A.
        • Liga R.
        • Giorgetti A.
        • et al.
        Assessment of myocardial adrenergic innervation with a solid-state dedicated cardiac cadmium-zinc-telluride camera: first clinical experience.
        Eur Heart J Cardiovasc Imaging. 2014; 15: 575-585
        • Nakajima K.
        • Nakata T.
        • Yamada T.
        • et al.
        A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging.
        Eur J Nucl Med Mol Imaging. 2014; 41: 1673-1682
        • Køber L.
        • Thune J.J.
        • Nielsen J.C.
        • et al.
        Defibrillator implantation in patients with nonischemic systolic heart failure.
        N Engl J Med. 2016; 375: 1221-1223
        • Moreira R.I.
        • Abreu A.
        • Portugal G.
        • et al.
        Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.
        J Nucl Cardiol. 2020; 27: 283-329
        • Gimelli A.
        • Liga R.
        • Menichetti F.
        • et al.
        Interactions between myocardial sympathetic denervation and left ventricular mechanical dyssynchrony: a CZT analysis.
        J Nucl Cardiol. 2019; 26: 509-518
        • Jacobson A.F.
        • Senior R.
        • Cerqueira M.D.
        • et al.
        Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study.
        J Am Coll Cardiol. 2010; 55: 2212-2221
        • Travin M.I.
        • Henzlova M.J.
        • van Eck-Smit B.L.F.
        • et al.
        Assessment of 123I-mIBG and 99mTc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: intermediate severity innervation defects are associated with higher arrhythm.
        J Nucl Cardiol. 2017; 24: 377-391
        • Sasano T.
        • Abraham M.R.
        • Chang K.C.
        • et al.
        Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.
        J Am Coll Cardiol. 2008; 51: 2266-2267
        • Irkle A.
        • Vesey A.T.
        • Lewis D.Y.
        • et al.
        Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography.
        Nat Commun. 2015; 6: 7495
        • Joshi N.V.
        • Vesey A.T.
        • Williams M.C.
        • et al.
        18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
        Lancet. 2014; 383: P705
        • Tzolos E.
        • Dweck M.R.
        18F-Sodium fluoride (18F-NaF) for imaging microcalcification activity in the cardiovascular system.
        Arterioscler Thromb Vasc Biol. 2020; 40: 1620-1626
        • Cartlidge T.R.G.
        • Doris M.K.
        • Sellers S.L.
        • et al.
        Detection and prediction of bioprosthetic aortic valve degeneration.
        J Am Coll Cardiol. 2019; 73: 110
        • Andrews J.P.M.
        • MacNaught G.
        • Moss A.J.
        • et al.
        Cardiovascular 18F-fluoride positron emission tomography-magnetic resonance imaging: a comparison study.
        J Nucl Cardiol. 2021; 28: 1-12
        • Andrews J.P.M.
        • Trivieri M.G.
        • Everett R.
        • et al.
        18F-fluoride PET/MR in cardiac amyloid: a comparison study with aortic stenosis and age- and sex-matched controls.
        J Nucl Cardiol. 2022; 29: 741-749